Newsletter | November 6, 2026

11.06.26 -- Resilience, AI & What's Next For Life Sciences

FEATURED ARTICLE

The Bond Factor: Resilience Through Change

Resilience isn’t just enduring change. It’s knowing when to adapt, let go and move forward. Wanda Shoer offers advice for navigating work and professional changes effectively. Explore how leaders can build trust, listen well and help teams navigate what’s next.

INDUSTRY INSIGHTS

The Future Of Clinical Trials: AI, Real-Time Data, And FDA Innovation

How can embedding trial protocols into health records deliver key safety and efficacy signals to sponsors and regulators in days, reducing manual data entry and accelerating decisions?

Supply Resiliency For Bioprocessing Amid Global Volatility

Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

Our Approach To Regulatory Compliance In China

Leverage proven regulatory expertise and local support to turn China’s rigorous API requirements into a clear, efficient pathway to market success.

Top 10 HEOR Trends Report

Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.

Are Your Trial Payments Creating Hidden Compliance Risks?

Clear separation of reimbursements, stipends, and site payments helps reduce compliance risk, improve transparency, and support ethical compensation.

Building A Path To Approval With Effective Regulatory Support

When partnering with CDMOs, success depends heavily on collaboration with a partner that combines deep technical expertise with a proven record of regulatory excellence and operational reliability.

Connect With Life Science Leader: